Besides, SLC12A5 expression was significant with MLH1 in nine tumor types, with MSH2 in four cancers, with MSH6 in five tumors, with PMS2 in six tumor types, and with EPCAM in four cancer types (Figure 6(d)). Here, MSH2 is linked to neoplasm.